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Abstract: Bone marrowmesenchymal stem cells (MSCs)
are candidate cells for cartilage tissue engineering. This is
due to their ability to undergo chondrogenic differentia-
tion after extensive expansion in vitro and stimulation
with various biomaterials in three-dimensional (3-D)
systems. Collagen type II is one of the major components
of the hyaline cartilage and plays a key role inmaintaining
chondrocyte function. This study aimed at analyzing the
MSC chondrogenic response during culture in different
types of extracellular matrix (ECM) with a focus on the
influence of collagen type II on MSC chondrogenesis.
Bovine MSCs were cultured in monolayer as well as in
alginate and collagen type I and II hydrogels, in both
serum free medium and medium supplemented with
transforming growth factor (TGF) b1. Chondrogenic
differentiation was detected after 3 days of culture in 3-D
hydrogels, by examining the presence of glycosamino-
glycan and newly synthesized collagen type II in the ECM.
Differentiation was most prominent in cells cultured in
collagen type II hydrogel, and it increased in a time-
dependent manner. The expression levels of the
of chondrocyte specific genes: sox9, collagen type II,
aggrecan, and COMP were measured by quantitative
‘‘Real Time’’ RT-PCR, and genes distribution in the
hydrogel beads were localized by in situ hybridization.
All genes were upregulated by the presence of collagen,
particularly type II, in the ECM. Additionally, the chondro-
genic influence of TGF b1 on MSCs cultured in collagen-
incorporated ECMwas analyzed. TGF b1 and dexametha-
sone treatment in the presence of collagen type II
provided more favorable conditions for expression of
the chondrogenic phenotype. In this study, we demon-
strated that collagen type II alone has the potential to
induce and maintain MSC chondrogenesis, and prior
interaction with TGF b1 to enhance the differentiation.
 2006 Wiley Periodicals, Inc.
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INTRODUCTION
Stem cells are undifferentiated cells that are defined by their
ability, at the single cell level, to self-renew and to
differentiate to produce mature progeny cells, which include
both nonrenewing progenitors and terminally differentiated
effectors (Wagers and Weissman, 2004). Bone marrow
mesenchymal stem cells (MSCs) are currently among the
best characterized adult stem cells (Majumdar et al., 1998;
Pittenger et al., 1999) isolated from various tissue sources
such as fat, muscle, and bone (Jiang et al., 2002b; Sottile
et al., 2002; Zuk et al., 2002). These cells are able to
differentiate into bone, fat, cartilage, muscle tissue, and
neurons (Mackay et al., 1998;Reyes et al., 2001; Sekiya et al.,
2004;Woodbury et al., 2000) and were ultimately reported in
almost all cell lineages (Jiang et al., 2002; Krause et al.,
2001). For these reasons, the isolation and manipulation of
adult stem cells represents a promising tool for understanding
tissue development and regeneration, as well as for studying
the engineered repair of tissues and organs (Orlic et al., 2001;
Pittenger and Martin, 2004; Wakitani et al., 2002).
The extracellular molecular signaling pathways are being
actively investigated. Extracellular signaling involves the
interaction of cell surface receptors with soluble cytokines
and growth factors, with the extracellular matrix (ECM),
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such as collagen and proteoglycans, or with the surface
proteins of the neighboring cells (Heng et al., 2004).
In addition to maintaining the structural integrity of the
tissues, the ECMhas physiological functions, such as passing
nutrients to the cells, acting as a reservoir for physiological
mediators, and mediating cellular functions through interac-
tion with cell surface receptors (Comper, 1996). The
integrins are a major family of ECM receptors that transmit
information from the matrix to the cells, thereby playing a
key role in the regulation of cell survival, proliferation,
differentiation, and matrix remodeling (Loeser, 2002).
Articular cartilage is an avascular tissue composed of
chondrocytes and ECM, which predominantly consists of
collagen type II, aggrecan, and hyaluronic acid. In addition to
these macromolecules, collagen types VI, IX, XI; decorin;
biglycan, cartilage oligomeric matrix protein (COMP); and
fibromodulin are also present in minor concentrations (Muir,
1995; Poole et al., 2001). It is well known that damaged
articular cartilage has poor intrinsic regenerative capacity.
Cell therapy using chondrocytes or their precursors
embedded in some biocompatible scaffold is a possible
approach for hyaline cartilage reconstruction. Such three-
dimensional (3-D) support is required for articular chon-
drocytes tomaintain their differentiated phenotype in vitro or
for the MSC to undergo chondrogenesis (Lemare et al.,
1998). Materials such as agarose, collagen, fibrin, alginate,
and biopolymers have all been used as 3-D scaffolds for
chondrocytes and MSC cultures (Batorsky et al., 2005;
Huang et al., 2004; Kavalkovich et al., 2002; Mueller
and Glowacki, 2001; Ponticiello et al., 2000; Wayne
et al., 2005).
In order to induce MSC chondrogenesis, factors that
support strong cell–cell interaction, growth factors, and an
environment that maintains spherical morphology, such as
polymer gels, are all important. Strong cell–cell interaction
mediated by cell adhesion molecules such as N-cadherin and
integrins allow MSC conversion to prechondroblasts at the
precartilage mesenchymal condensation stage during limb
development (Haas and Tuan, 1999; Hall andMiyake, 1995).
Various bioactive factors, such as fibroblast growth factor,
transforming growth factors (TGF) b1 and b3, bone
morphogenic proteins (BMPs)-2, -6, and -9, and insulin-like
growth factors, have been reported to induce or maintain
chondrogenesis (Indrawattana et al., 2004; Muraglia et al.,
2000; Sekiya et al., 2002).
Although there has been an increase in information
regarding the role of growth factors and cytokines as inducers
and mediators of MSC differentiation, little is known about
the influence of ECM on MSC chondrogenic differentiation.
Even less is known regarding the nature of communication
and the mechanism of interaction between the MSCs and the
cartilaginousmatrix during embryogenesis or homeostasis of
articular cartilage.
The goals of this study were to analyze the influence of
different types ofECM,particularly collagen type II, onMSC
chondrogenesis with or without interaction with the chon-
drogenic growth factor TGF b1. Ultimately, these studies
may contribute to a better understanding of the development,
physiology, and regeneration of articular cartilage.
MATERIALS AND METHODS
Harvest and Isolation of Bovine MSC
Bone marrow was aspirated from four calves (2 months old),
and MSCs were isolated by previously described methods
(Bosnakovski et al., 2004, 2005). Briefly, the bone marrow
sample was washed twice with phosphate buffered saline
(PBS), and twice again with Dulbecco’s Modified Eagle
Medium (DMEM; GIBCO BRL, Grand Islands, NY). After
determination of the cell viability and number, 5 104/cm2
nucleated cells were plated in medium that consisted of
DMEM (low glucose) containing penicillin G 100 U/mL,
streptomycin 100 mg/mL, amphotericin B 0.25 mg/mL,
HEPES 2.4 mg/mL, NaHCO3 3.7 mg/mL, and 10% fetal
bovine serum (FBS; lot No. 5300C, ICN, Biomedicals,
Aurora, OH), and cultured at 378C in a humidified atmo-
sphere containing 5% CO2 until the second passage.
Experiments were performed with at least six different
isolated cell lines.
Hydrogel Preparation
Alginate and collagen type I and II hydrogels were prepared
using a combination of previously reported protocols
(Elisseeff et al., 2002; Qi and Scully, 2002). An alginate
solution (1.5%) prepared from low-viscosity sodium alginate
(WakoPureChemicalCo., Osaka, Japan) in 0.15MNaClwas
sterilized by filtering through a 0.45mmfilter. For preparation
of collagen type I or II hydrogels, 700 mL of collagen type I
or II solutions (0.3%, Koken Co., Tokyo, Japan) were
neutralized with 100 mL HEPES buffer and mixed with
280 mL 1.5% alginate solution. A minimum of 35% alginate
in the mixturewas necessary to obtain a solid hydrogel. Cells
from the second or third passage were harvested with 0.25%
trypsin in 0.02% EDTA, and then divided in three parts.
Each part was mixed with one of the hydrogels to a final
concentration of 1–2 106 cells/mL solution. Cells/hydro-
gel suspensionwas slowly dropped into 102mMCaCl2 using
a pipette tip (2–200 mL). After initial gelatinization, the
beads were allowed to polymerize for 10 min. Subsequently,
they were washed three times with 0.15 M NaCl and once
with DMEM and were cultured overnight at 378C/5% CO2.
The polymerized alginate solution formed compact spherical
beads of 2–3 mm diameter. Collagen type I and II hydrogels
had a more discoid shape, approximately 2 4 mm in size.
They could not polymerize to typical beads prior to contact
with CaCl2 because of the low alginate concentrations. On
the following day, the beads were transferred to six-well cell
culture plates (16 beads/well), and theywere cultured in plain
or chondrogenic medium for 21 days. The plain mediumwas
a serum-free chemically defined medium consisting of
DMEM (high glucose), insulin 6.25 mg/mL, transferin
6.25 mg/mL, selenious acid 6.25 mg/mL, bovine serum
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albumin 1.25 mg/mL, pyruvate 1 mM, linoleic acid 5.35 mg/
mL, and ascorbate 2-phosphate 50 mg/mL (all from Sigma
Chemical Co., St. Louis, MO). The chondrogenic medium
was plain medium supplemented with 10 ng/mLTGF b1 (R
& D Systems, Minneapolis, MN) and 100 nM dexametha-
sone (Sigma Chemical Co.).
MSCs cultured in monolayers were used as a control, for
comparing the influence of the type of culture system
(monolayer and 3-D) on chondrogenesis. Aliquots of the
cells used for hydrogel preparation were plated (5
103 cells/cm2) in six-well plates and cultured in plain and
chondrogenic medium under conditions similar to those of
cells in hydrogels.
Histological and Immunohistochemical Analysis
of the Hydrogel Beads
Samples were harvested at the beginning of the experiment
(day 0) and after 3, 6, and 21 days of culture. They were fixed
in 10% neutral buffered formalin containing 0.1 M CaCl2
for 2 days and embedded in paraffin. Hematoxylin and eosin
(H&E) staining of paraffin sections (4 mm)was performed to
evaluate cell morphology in the beads. Sulfated glycosami-
noglycans (GAGs) were visualized by staining with 0.5%
alcian blue (pH 1.0) for 10 min. Newly synthesized collagen
type II was detected using polyclonal rabbit anti-bovine
antibody (LSL Co., Tokyo, Japan). Briefly, after deparaffi-
nization, the sections were predigested with 2.5% hyalur-
onidase (Type I–S, SigmaChemicals Co.) for 30min at 378C
to facilitate antibody access. Endogenous peroxidase was
quenched by treatment with 0.3% H2O2 in methanol at room
temperature for 30 min, and nonspecific antibody binding
was blocked by incubating sections in 10% normal goat
serum at 378C for 30 min. Primary antibody was diluted
1:500 in 0.05M Tris buffer (pH 7.6) and applied overnight at
48C. Sections were then incubated with the secondary
antibody, swine anti-rabbit immunoglobulin (DAKO,
Glostrup, Denmark), for 60 min, followed by detection with
the rabbit PAP kit (DAKO). Collagen type II was visualized
by reactionswith 0.05%diaminobenzidine containing 0.01%
H2O2.
In Situ Hybridization
For in situ hybridization, hydrogel beads harvested on day 0,
3, 6, and 21 were embedded in OCT embedding medium
(Tissue-Tek; Sakura Finetechnical Co., Tokyo, Japan) and
frozen in liquid nitrogen. Frozen sections (10 mm) were cut
and mounted on silane-coated glass slides. Two kinds of
nonoverlapping 45-m antisense oligonucleotide probes were
synthesized to detect every mRNA of interest. The following
genes sequences were used: for collagen type I, nucleotide
residues 2408–2453 and 4108–4153 (Gen Bank
AB008683); for collagen type II, nucleotide residues 278–
323 and 777–822 (Gen Bank X02420); and for aggrecan,
nucleotide residues 5540–5585 and 6750-6795 (Gen Bank
U76615). Oligonucleotides were labeled with 35S-adenosine
thiotriphosphate to a specific activity of 0.5 109 dpm/mg
DNA, using terminal deoxynucleotidyl transferase. Sections
were fixed with 4% paraformaldehyde in 0.05 M Tris buffer
(pH 7.6) for 15 min, and acetylated with 0.25% acetic
anhydride in 0.1M triethanolamine-HCl (pH 8.0) for 10min.
Hybridization was performed at 428C overnight by reaction
with labeled oligonucleotide probes at a final radioactivity
of 0.5 107 cpm/mL in 50% formamide, which contained
30 mM Tris-HCl (pH 7.4), 0.6 M NaCl, 1 mM EDTA,
100 mM dithiothreitol, 1 Denhardt’s solution, 0.25%
sodium dodecyl sulfate, 10% dextran sulfate, and 200 mg/
mL yeast tRNA. Control hybridization was performed in the
presence of 20-fold excess amount of unlabeled antisense
probe. Slides were washed in 2 SSC containing 0.1%
sarkosyl for 30 min at room temperature, followed by
washing twice in 0.1 SSC/0.1% sarkosyl for 40 min at
558C. Slides were dipped into autoradiographic emulsion
(NTB-2, Kodak, Rochester, NY), exposed at 48C for 3weeks,
and counterstained with hematoxylin.
Isolation of RNA From the Hydrogels
and cDNA Synthesis
On days 0, 3, 6, and 21, beads (n¼ 6–8) were transferred
to 1.5 mL centrifuge tubes and dissolved with 1 mL
reconstruction buffer (50 mM EDTA and 10 mM HEPES in
0.15 M NaCl) for 10 min at 378C. The cell suspension was
centrifuged (200g) and the cell pelletswerewashed oncewith
PBS. Total RNA from reconstructed cells and cells from the
monolayer was isolated using Trizol (Invitrogen, Life
Technologies, Carlsbad, CA) according to the manufac-
turer’s instructions. Samples were treated with DNase to
remove possible genomic DNA contamination. Subse-
quently, first-strand cDNA was synthesized in a 20 mL
reaction mixture from 2 mg total RNA using M-MLV reverse
transcriptase (Invitrogen) with oligo (dT)20 as a primer. The
sample that did not contain transcription enzyme in the
reaction mixture was used as the negative control for
checking genomic contamination.
To compare level of MSC chondrogenesis and for positive
control in PCR reaction, total RNA was harvested from
bovine chondrocytes that were isolated by collagenase
digestion of articular cartilage pieces from the same donors
as those for bone marrow (Bosnakovski et al., 2004).
Measurement of Gene Expression by a
Quantitative ‘‘Real Time’’ RT-PCR
(qRT-PCR) Method
The amount of cDNAwas measured by a qRT-PCR method
using the Smart Cycler System (Cepheid, CA). The PCR
reaction was carried out in 25 mL final volume, which
contained PCR buffer, 3 mMMgCl2, 0.3 mM dNTPmixture,
0.3 mM each of bovine specific primer (Table I), and Taq
polymerase (1.25 U/tube; Takara Biomedicals, Otsu, Japan).
Thermal cycling was carried out for 45 cycles at 958C for 5 s,
55–608C for 15 s, and 758C for 15 s. The amount of PCR
product was estimated using absolute quantification method;
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by measuring the intensity of the fluorescence of SYBR
Green I interacted into the PCR product and compared to the
standard curve of every gene, separately. The mRNA ex-
pression levels of target genes were normalized by dividing
their value by the value of the glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA level. The quality of the
PCR products was checked by melting curve analysis,
electrophoresis, and sequencing.
Statistical Analyses
Data were evaluated from at least six independent experi-
ments and are represented as mean SD. One-Way ANOVA
followed bymultiple pairwise comparisonswas performed to
determine differences among the groups. The results were
considered significantly different at P< 0.05.
RESULTS
Histological and Immunohistochemical
Determination of the Chondrogenesis
To evaluate the effect of various ECM components on
chondrogenesis, we cultured bovine MSCs in hydrogels
composed of alginate, collagen type I and II. Structural
organization and cell proliferation, deposition of sulfated
GAG, and the presence of newly synthesized collagen type II
in hydrogels were analyzed on days 0, 3, 6, and 21, by H&E,
alcian blue, and immunohistochemical staining, respectively,
(Fig. 1). Homogeneous cell distribution throughout the bead
was observed in all types of hydrogels. During the culture
period, the cells proliferated in all types of cultures, with a
notable increased proliferation rate in collagen hydrogels and
in chondrogenic medium (data not shown). Cells maintained
a round plump shape, characteristic of chondrocytes, and
formed cell clusters during the culture period. Chondrogen-
esis was detected in all hydrogels, regardless of the type of
culture medium (plain or chondrogenic). Detected GAG and
collagen type II gradually increased during the culture
period, and the difference in the staining intensity at day 0 and
day 21 was obvious under all experimental conditions
(Fig. 1). Among the various types of hydrogel and media,
the chondrogenic markers were best expressed in cells
cultured in collagen type II ECM and in chondrogenic
medium, respectively. However, prior interpretation of the
results it has to be considered that all three types of hydrogels
have different physical properties (density, porosity, water
contents, cells seeding efficiency), which can influence
proliferation and differentiation ability of the cells.
In the present trial,MSCs from the second or third passage,
independently, were used for the preparation of hydrogels.
Cells from these two passages did not show any significant
difference in the potential to undergo chondrogenic differ-
entiation.
Quantitative Analyses of Chondrocyte-Related
Gene Expression
Gene expression was analyzed by qRT-PCR in the differ-
entiated cells produced by the various culture conditions
(monolayer and 3-D culture), ECM (alginate and collagen
types I and II), and culturing medium (plain serum-free and
chondrogenic-TGF b1/dexamethasone supplemented med-
ium). We assayed panel of chondrocyte-related genes:
collagen type II (coll 2), aggrecan (agg), COMP, early
chondrogenic transcription factor sox9, and a marker for
hypertrophic chondrocytes, collagen type X (coll 10).
Cells cultured in monolayers in serum-free medium
expressed only basal levels of agg, coll 2, and coll
10 mRNA, but not of sox9 and COMP. Conversely, cells
cultured in 3-D systems, in plainmedium, began to express or
significantly increased the expression of chondrogenic genes
just after 3 days (Figs. 2A and 3A). Sox9 showed markedly
different expression between cells cultured in monolayers
and in 3-D culture, being detection in all hydrogels,
regardless of the medium (Fig. 4A). Sox9 is a member of
the Sox (Sry-type HMG box) gene family, which are
predominantly expressed in mesenchymal condensation
and cartilage, and has been shown to activate type II collagen
and aggrecan (Tsuchiya et al., 2003). We observed coll 2,
Table I. Bovine marker genes used in quantitative ‘‘Real Time’’ RT-PCR (qRT-PCR).
Gene Primer nucleotide sequence Product size (bp) Accession number
GAPDH Forward 50 CCTTCATTGACCTTCACTACATGGTCTA 127 U85042
Reverse 50 TGGAAGATGGTGATGGCC TTT CCATTG
Collagen type I Forward 50 TGC TGG CCA ACC ATG CCT CT 120 AB008683
Reverse 50 CGA CAT CAT TGG ATC CTT GCA G
Collagen type II Forward 50 ATC CAT TGC AAA CCC AAA GG 147 X02420
Reverse 50 CCA GTT CAG GTC TCT TAG AG
Collagen type X Forward 50 CAT GCT GCC ACA AAC AGC 110 X53556
Reverse 50 TGG ATG GTG GGC CTT TTA
Aggrecan Forward 50 CAC TGT TAC CGC CAC TTC CC 303 U76615
Reverse 50 GAC ATC GTT CCA CTC GCC CT
Sox9 Forward 50 CAT GAA GAT GAC CGA CGA G 118 AF278703
Reverse 50 CGT CTT CTC CGT GTC GGA
COMP Forward 50 TTC GGA ACG CAC TGT GG 112 X74326
Reverse 50 TGC AGG AAC CAG CGG TA
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agg, andCOMP expression at a later time point in 3D culture,
consistent with an early activating role of sox9. The levels of
coll 2 and aggmRNAcontinued to increase in collagen type I
and II hydrogels from day 3 to day 21; however, they were
maintained constant in alginate hydrogel.
In collagen type II hydrogel, from day 0 to day 6 and day 0
to day 21, coll 2 increased 99- and 155-fold, and agg
increased 12- and 31-fold, respectively (Figs. 2A and 3A). In
alginate, on day 3, coll 2 and agg were upregulated
approximately 40-fold and threefold, respectively, and this
Figure 1. Mesenchymal stem cells (MSCs) cultured in alginate, and collagen types I and II hydrogels on days 0, 6, and 21 in serum-free and chondrogenic
media, analyzed by hematoxylin and eosin (H&E), alcian blue (Al), and immunohistochemical staining (Im) for detection of type II collagen.Cells had a round,
plump shape throughout the beads. Cell proliferation was obvious during the culture period, and on day 21, cells organized in clusters were noticeable (white
arrows). Further, a significantly increased proliferation rate was detected in beads cultured in TGF b1 supplemented medium. Positive metachromatic staining
and immunoreactivity for type II collagenwas detected on day 3, and the intensity increased in a time-dependentmanner. Scale bar 125 mm. [Color figure can be
seen in the online version of this article, available at www.interscience.wiley.com.]
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expression level remained constant during the culture period.
Collagen types I or II incorporated in ECM significantly
induced the expression of coll 2 mRNA, and on day 21, it
showed approximately 3.2-fold increase over that of alginate
beads (P< 0.05). The expression of agg mRNA was also
highest in the cells cultured in collagen type II, and on day 21
it showed 3.2- and 1.9-fold increase over that of alginate and
collagen type I hydrogels (P< 0.01), respectively. In
addition to the chondrogenic effect of the different 3-D
cultures, we analyzed the influence of interaction among
cells, ECM, and the potent bioactive factors, TGF b1 and
dexamethasone on MSC differentiation. MSCs in mono-
layers stimulated by TGF b1 demonstrated increased but
limited chondrogenic gene expression. The effect of this
chondrogenic biofactor on gene expression was greatly
enhanced in the 3-D culture system, followed by deposition
of newly synthesized collagen type II in the ECM (Fig. 1). In
the collagen type II hydrogel, on day 6, the coll 2mRNAwas
upregulated 2.8-fold in the chondrogenic medium in
comparison with the plain medium (P< 0.05; Fig. 2).
Interestingly, TGF b1 had a suppressive effect on agg
mRNA, and on day 6, the expression decreased 30% in
comparison with the plain medium (Fig. 3). A significant
difference (P< 0.01) between the plain and chondrogenic
media was found in all hydrogels, with approximately
fivefold higher expression of COMP mRNA (Fig. 4B).
COMP is one of the major noncollagenous proteins in
cartilage and is reported to be an even more sensitive marker
than collagen type II for the differentiation state of bovine
articular chondrocytes (Zaucke et al., 2001). The expression
of sox9 and coll 10 was also stimulated by TGF b1 (Fig. 4A
and B); for example, in collagen type II ECM, after 6 days of
culture, coll 10 increased 1.8-fold in chondrogenic medium
over plain medium (P< 0.05). Collagen type X is a marker
for hypertrophic cartilage, which undergoes endochondral
ossification and for articular chondrocytes that have become
hypertrophic in osteoarthritis (Eerola et al., 1997; Gibson
et al., 1997).
Additionally, we analyzed the influence of the ECM and
the type of medium on the expression of coll 1 mRNA in
MSCs (Fig. 5). This gene is one of the markers for the de-
differentiation of chondrocytes (Schulze-Tanzil et al., 2002).
During culturing in monolayer, chondrocytes shift expres-
sion from coll 2 to coll 1. MSCs cultured in monolayers and
alginate cultures tended to increase coll 1 expression
(Fig. 5A). On the other hand, cells cultured for 21 days in
collagen type I and particularly type II hydrogels showed a
2.3- and 2.8-fold decrease in expression compared with that
of alginate (P< 0.05 and P< 0.01). In all culture conditions
except collagen type I ECM, the coll 1 mRNA was
significantly (P< 0.01) downregulated by the chondrogenic
medium, compared with the same experimental group
cultured in plain medium.
Figure 2. Quantitative analysis of collagen type II (coll 2) gene expression
of MSCs cultured in plain (serum-free: (a)) and chondrogenic (TGF b1/
dexamethasone: (b) media. The expression level was normalized with
respect to the expression level of GAPDH mRNA. The expression level of
coll 2mRNA in the collagen type II hydrogel in plain medium on day 6 was
represented as one. Data were evaluated from seven independent experi-
ments and were represented as meanSD.
Figure 3. Quantitative analysis of aggrecan (agg) gene expression of
MSCs cultured in plain (a) and chondrogenic (b)media. The expression level
was normalized with respect to the expression level of GAPDHmRNA. The
expression level of agg mRNA in the collagen type II hydrogel in plain
medium on day 6 was represented as one. Data were represented as
meanSD.
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We compared gene expression level in chondrocytes
produced in vitro (MSCs cultured for 6 days in collagen type
II hydrogels and in chondrogenic medium) to that of primary
isolated chondrocytes, cultured overnight in monolayers
(Table II). While coll 2, agg, andCOMP could be detected at
responsibly similar levels, primary chondrocytes expressed
very low to undetectable level of sox9, coll 10, and coll 1.
Expression of sox9 in freshly isolated chondrocytes could not
be detected under equivalent RT-PCR conditions. However,
with increasing sensitivity of the reactions, a low expression
level of this gene was also detected (data not shown).
Localization of Gene Expression in the Hydrogels
In order to confirm the results from qRT-PCR and to localize
mRNA expression in the hydrogel beads, we performed
in situ hybridization for coll 1, coll 2, and agg mRNA
(Figs. 6–8). The highest level of coll 2 and agg expression
was detected in cells cultured in collagen type II ECM. The
intensity of the signal increased with culture time and with
the presence of TGF b1 in the medium. After 21 days of
culture in plain medium, distribution of coll 2 mRNA was
evident in the center of the collagen bead. On the other hand,
after short (6 days) treatment with TGF b1, coll 2 was
prominently detected in the cells at the periphery of the
beads. This pattern of coll 2 mRNA distributions was not
notable in the alginate beads. Similar to coll 2, strong coll 1
mRNA expression was detected in the center of the collagen
type I hydrogel after 21 days of culture in plain medium. The
incorporated collagen was most concentrated in the center of
the beads where expression of chondrogenic-related genes
Figure 4. Quantitative analysis of sox9 (a), COMP (b), and collagen type
X (coll 10; (c)) gene expression inMSCs cultured for 6 days. The expression
level was normalized based on the GAPDH mRNA level. Expression levels
of sox9, COMP, and coll 10mRNA in the collagen type II hydrogel in plain
mediumwere each represented as one. Valueswere expressed asmeanSD.
Figure 5. Quantitative analyses of collagen type I (coll 1) gene expression
of MSCs cultured in plain (a) and chondrogenic (b) media. The expression
level was normalizedwith respect to the expression level of GAPDHmRNA.
The expression level of coll 1mRNA in the collagen type II hydrogel in plain
medium on day 6 was represented as one. Data were represented as
mean SD.
Table II. qRT-PCR analyses of chondrocyte-related gene expression in
mesenchymal stem cells (MSCs) cultured for 6 days in collagen type II
hydrogel and chondrogenic medium, and primary chondrocytes cultured
overnight in 10% FBS-supplemented medium.
Gene MSC Chondrocytes
Collagen type II 1.00 0.38 1.89 0.21
Aggrecan 1.00 0.33 1.70 0.36
Sox9 1.00 0.31 Not detected
COMP 1.00 0.22 0.42 0.07
Collagen type X 1.00 0.21 0.03 0.01
Collagen type I 1.00 0.32 0.01 0.003
The gene expression level in MSCwas represented as 1SD and that in
chondrocytes was represented as fold difference SD.
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Figure 6. In situ hybridization of the alginate, collagen type I and II hydrogels on day 0, 6, and 21 for detection of coll 2 mRNA. Scale bar 250 mm.
Figure 7. In situ hybridization of the alginate, collagen type I and II hydrogels on day 0, 6, and 21 for detection of agg mRNA. Scale bar 250 mm.
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was the highest, confirming the previous suggestion that
collagen was the dominant factor for MSC chondrogenesis.
DISCUSSION
By analyzing gene and protein expression, we have
demonstrated the influence of various 3-D hydrogel cultures
in inducing and maintaining MSC chondrogenic differentia-
tion. Chondrogenesis of bovineMSCs occurred under serum-
free condition and was greatly enhanced in media containing
TGF b1. Among the different types of hydrogels, collagens
type I and II showed the greatest degree of induced
differentiation. Between the two types of collagen, type II
was slightly better based on cell morphology and chondro-
genic gene expression panel.
In order to resolve and understand the complexities of
chondrogenesis, it is necessary to follow the process through
different culture systems since each of these has certain
limitations (Sekiya et al., 2002). Using a bovine experimental
model, we have previously analyzedMSC chondrogenesis in
monolayer cultures in response to TGF b1 stimulation
(Bosnakovski et al., 2005).We also demonstrated that bovine
MSC has the potential for self-inducing chondrogenic
differentiation independent of any externally added biosti-
mulants, if strong cell–cell interaction in the condensate
pellet culture system is allowed (Bosnakovski et al., 2004).
Having already determined the importance of strong cell–
cell interaction and the influence of TGF b1 in MSC
chondrogenesis, we proceeded to assess the influence of
ECM on MSC chondrogenic differentiation.
It is well known that cells must interact with their
microenvironment, fromwhere soluble and insoluble signals
trigger physiological responses through contact with the cell
surface to maintain homeostasis. Various materials incorpo-
rated in 3-D culture systems have been shown to be useful
tools in studying chondrogenesis, chondrocytes, and matrix
biology (Qi and Scully, 2002; Wayne et al., 2005). In order
to clarify the influence of the collagen ECM on MSC
differentiation, we used two control groups. One was a
monolayer culture and the other was a well-documented
alginate hydrogel that allows certain macromolecules, such
as collagen fibers, to be incorporated within it. Alginate is a
polysaccharide extracted from seaweed that forms an ionic
gel in the presence of divalent cations such as Ca. Easy
manipulation of cell density in suspensions of this type of
culture offers a well-controlled system for studying cell–cell
and cell–matrix interactions. Chondrocytes encapsulated in
alginate remain differentiated, as opposed to cells cultured in
monolayers, which become fibroblastic (Hauselmann et al.,
1994). Moreover, MSCs in beads of this polymer that were
cultured in medium containing TGF or BMP-2, -6, or -9
underwent chondrogenic differentiation (Ma et al., 2003;
Majumdar et al., 2001). Bovine MSCs seeded in alginate
beads also maintained a spherical form and increased
the expression of chondrocyte-specific genes under TGF b1
treatment.
In the present trial, the cell–matrix interaction was the
priority; therefore, the MSCs were cultured at a low initial
seeding density (1–2 106 cells/mL hydrogel solution), and
we attempted to reduce the alginate percentage in the
Figure 8. In situ hybridization of the alginate, collagen type I and II hydrogels on day 0, 6, and 21 for detection of coll 1 mRNA. Scale bar 250 mm.
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collagen hydrogels as much as possible. It was reported that
the most prominent MSC chondrogenesis in cells cultured in
an alginate layer occurs at an initial density of 25 106 cell/
mL, while GAG synthesis dropped off precipitously in
cultures of lower cell density (Kavalkovich et al., 2002).
Collagen type I is a major organic component of bones.
Osteoblasts maintain their phenotype when cultured in
collagen type I containing ECM, while MSCs undergo
osteogenesis (Lynch et al., 1995;Mizuno et al., 1997). Thea2
integrin subunit is a component of a major collagen type I
receptor a2b1 integrin. Interaction of this subunit with
collagen type I leads to osteoblastic differentiation of MSCs,
which is a crucial event in the expression of the osteogenic
phenotype (Mizuno et al., 2000). Chondrocytes cultured in
collagen type I gel grew in three dimensions, accumulating a
cartilaginous ECM while maintaining their round morphol-
ogy during the culture period (Kimura et al., 1987; Uchio
et al., 2002). Furthermore, a cartilage defect was partially
repaired when human autologous culture-expanded MSCs
engineered in a collagen type I gel were transplanted into an
osteoarthritic knee (Wakitani et al., 2002). Our results
showed that cells cultured in collagen type I hydrogel and
in medium containing TGF b1, and dexamethasone
expressed significantly high levels of coll 1 mRNA. MSCs
undergo osteogenic differentiation upon treatment with
dexamethasone or TGF b1, which is followed by increased
expression of coll 1mRNA (Andrades et al., 1999; Gronthos
et al., 2003; Phinney et al., 1999). Damaged articular
cartilage is usually substituted by fibrous cartilage of which
collagen I is a component. We analyzed the influence
of collagen type I on MSCs as we were interested in
how collagen type I would affect MSC chondrogenesis prior
to cell transplantation in a cartilage defect. It appears that
collagen type I ECM in combination with TGF b1 and
dexamethasone induced both chondrogenesis and osteogen-
esis, while collagen type II biases towards chondrogenesis.
Furthermore, hydrolyzed collagen type II and hydrolyzed
collagen type I were able to stimulate collagen type II
production in chondrocytes to almost the same extent (Oesser
and Seifert, 2003).
Collagen type II is a dominant component of hyaline
cartilage. Chondrocytes bind to collagen type II ligands
through a1b1, a2b1, and a10b1 integrins resulting in the
formation of signaling complexes that play roles in
differentiation, matrix remodeling, response to mechanical
stimulation, and cell survival (Loeser, 2002). Mitogen-
activated protein (MAP) kinase appears to play a central
role in mediating the downstream signal from integrins,
which can regulate gene expression through activation of
transcription factors such as AP-1 and NFkB. Our results
clearly demonstrated that the presence of collagen type II in
the ECM has the potential to induce and stimulate
chondrogenesis. Among all analyzed hydrogels, collagen
type II was the most favorable ECM for expressing the
chondrogenic phenotype since it resulted in upregulation of
each analyzed chondrogenic gene and synthesis of collagen
type II and GAG. Upregulation of sox9, coll 2, agg, COMP,
and coll 10mRNAare believed to represent the physiological
adaptation of MSCs to a specialized environment of the
articular matrix, which could be partly mediated by collagen
type II. Even, results to be most convincing, level of coll 1
mRNA, which is an indicator of chondrocyte de-differentia-
tion, was the lowest with a tendency of decreasing (Fig 5)
(Schnabe et al., 2002). Van der Kraan et al. (2002) found that
collagen type II is a better matrix for chondrocytes to
express their phenotype than collagen type I. Chondrocytes
significantly upregulatedDNA and proteoglycan synthesis in
a concentration-dependent fashion, according to the presence
of collagen type II in the ECM (Scully et al., 2001). In our
trial, cell proliferation was also stimulated in collagen-
containing hydrogels (data not shown). An earlier investiga-
tion that used collagen-GAG matrices found that while the
majority of cultured canine chondrocytes seeded in type I
collagen had a fibroblastic morphology, the majority of the
cells in type II collagen matrices had a chondrocyte
morphology and displayed an increase in GAG and collagen
type II production (Nehrer et al., 1997; Veilleux et al., 2004).
TGF b1, which is a well-documented potent chondrogenic
factor, is stored in a significant concentration in articular
cartilage, indicating that it is integral to chondrocyte and
matrix homeostasis (Pedrozo et al., 1998). The results from
our previous (Bosnakovski et al., 2005) and present studies
clearly indicate that MSCs cultured under various culture
conditions and treated with TGF b1 undergo chondrogenic
differentiation, which is time- and dose-dependent with
respect to the stimulants. TGF b1 exerts its effect through a
high-affinity interactionwith a heteromeric receptor complex
(type I and II) that comprises two structurally related serine-
threonine kinases. It transduces its signals through the Smad
pathway, leading to the activation of the sox9 transcription
mechanisms (Attisano and Wrana, 2002; Hatakeyama et al.,
2003). Chondrogenesis (by all parameters) was most
prominently induced in the cells cultured in collagen type
II ECM and treated with TGF b1. We demonstrated that
collagen type II ECM and TGF b1 individually had the
potential to induce chondrogenesis and that the best
differentiation was achieved when these two factors were
combined. The same effect was reported in chondrocytes,
and the specific regulation of TGF b1 in the presence of
collagen type II was hypothesized to occur through the
binding of b1 integrin and its action at the transcriptional,
posttranslational, or both levels (Scully et al., 2001). This
also confirms that signals received by cells from a soluble
regulator such as TGF b1 depend on a combination of factors
such as mechanical stimuli, presence of the regulators at the
cell differentiation level, and the presence of specific
pericellular matrix molecules, for example, collagen type II
(Vivien et al., 1990). It was proven by means of stimulating
cells cultured in different conditions by exogenous TGF b1
that the mechanism of action of TGF b1 and collagen on
chondrocytes is different; however, at the same time, these
factors do interact. Cells treated with TGF b1 produce
endogenous TGF b1; however, expression of the endogenous
product was downregulated in a dose-dependent manner by
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the presence of collagen types I or II in the ECM (Qi and
Scully, 2002). Shakibaei et al. (1999) reported that the
expression of the docking protein Shc, which is associated
with the Grb2 adaptor protein and the Ras signal pathway,
occurs only when chondrocytes were bound to collagen type
II or anti-b1 integrin antibodies. This expression increased
with the addition of IGF-I, suggesting collaboration between
integrins and growth factors in a common/shared biochem-
ical-signaling pathway. Furthermore, the binding of chon-
drocyte integrins to ECM molecules, such as fibronectin,
results in the intracellular formation of focal adhesion
plagues, which is a prerequisite for cells to respond to growth
factors such as FGF and IGF-I (Clancy et al., 1997; Martin
and Buckwalter, 1998).
In conclusion, to the best of our knowledge, the current
study is the first to provide evidence that collagen type II,
which acts as a physiological articular cartilage matrix, can
initiate and maintain MSC chondrogenesis, and that it
enhances the effect of TGF b1. Further understanding of
the cell response to ECM will allow more rational designing
and development of hydrogels and scaffolds for studying
MSC chondrogenic differentiation, articular cartilage devel-
opment and degeneration, andwould advance cartilage tissue
engineering.
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the help in preparation of the article.
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